Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit 
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy 
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 
FREMONT, Calif., March 01, 2016 -- WaferGen Bio-systems, Inc. (NASDAQ:WGBS), a life sciences tools company focused on developing and commercializing technology platforms for genomics solutions, announced today that it will announce fourth quarter and full-year 2015 financial results after the market close, and host a conference call and webcast on Tuesday, March 8, 2016.
| Conference Call & Webcast | |||||
| Tuesday, March 8th at 5:00 PM Eastern Time: | |||||
| Domestic: | 877-407-3982 | ||||
| International: | 201-493-6780 | ||||
| Conference ID: | 13631278 | ||||
| Webcast: | http://public.viavid.com/index.php?id=118499 | ||||
| Replays, available through March 22: | |||||
| Toll-Free: | 877-870-5176 | ||||
| International: | 858-384-5517 | ||||
| Conference ID: | 13631278 | ||||
About WaferGen
WaferGen Bio-systems, Inc. is a biotechnology company that offers innovative genomic technology solutions for single-cell analysis and clinical research. The single cell analysis platform is a revolutionary system which can isolate thousands of single cells and processes specific cells for analysis, including Next Generation Sequencing (NGS). The SmartChip platform can be used for profiling and validating molecular biomarkers, and can perform massively-parallel single-plex PCR for one-step target enrichment and library preparation for clinical NGS. These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell level in the life sciences, pharmaceutical, and clinical laboratory industries.
INVESTOR CONTACTS: LifeSci Advisors, LLC Brian Ritchie [email protected] WaferGen Bio-systems, Inc. Rollie Carlson [email protected]
